Effect of Anlotinib on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
JAMA Network - This randomized clinical trial examines the efficacy of anlotinib compared with placebo as a third-line or further therapy on overall survival of adult patients
https://t.co/W2nkqY3lf4